Some advanced epithelial ovarian cancer patients can avoid a lymphadenectomy without impacting survival outcomes

Monitoring ovarian function in oncology studies

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours

Cancer care in Needle Hospital, Hargeisa, Somaliland

Relapsed refractory multiple myeloma

Multiple myeloma (A cancer arising from plasma cells)

Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours

Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer

Pembrolizumab plus chemoradiotherapy shows clinically meaningful improvement in PFS for locally advanced cervical cancer

2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant pembrolizumab